Activities per year
- 43 results
Search results
-
Abbvie Taiwan Oncology Researchers Summit The Future of Epcoritamab to Tackle Hard-to-Treat Lymphoma
Linton, K. (Invited speaker)
30 Nov 2024Activity: Talk or presentation › Oral presentation › Research
-
Individualised dose mapping uncertainty estimation for head and neck cancer reirradiation
Thiong'o, C. M. (Speaker)
4 May 2024Activity: Talk or presentation › Oral presentation › Research
-
BSH 2024 Epcoritamab Monotherapy Leads to Deep and Durable Responses in R/R FL: Pivotal EPCORE NHL-1 Data
Linton, K. (Invited speaker)
28 Apr 2024Activity: Talk or presentation › Oral presentation › Research
-
JSMO 2024 Epcoritamab SC in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma (FL): EPCORE NHL-1 Dose Expansion
Linton, K. (Plenary speaker)
23 Feb 2024Activity: Talk or presentation › Oral presentation › Research
-
EHA 2024 S155: LATEST RESULTS FROM AN ONGOING FIRST-IN-HUMAN PHASE 1A/BSTUDY OF NX-5948, A SELECTIVE BRUTON’S TYROSINE KINASE (BTK)DEGRADER, IN PATIENTS WITH RELAPSED/REFRACTORY CLL AND OTHER B-CELL MALIGNANCIES
Linton, K. (Invited speaker)
2024Activity: Talk or presentation › Oral presentation › Research
File -
Manchester BRC Living With and Beyond Cancer Research hybrid event Reducing the impact of second cancers
Linton, K. (Speaker)
1 Nov 2023Activity: Talk or presentation › Oral presentation › Teaching and Research
-
Oxford Lymphoma Management Course Updates on the management of marginal zone lymphomas
Linton, K. (Speaker)
16 Oct 2023Activity: Talk or presentation › Oral presentation › Teaching
-
BSH 2023 Lymphoma Special Interest Group Meeting - MDT Dilemmas
Linton, K. (Speaker) & Walewska, R. (Speaker)
Oct 2023Activity: Talk or presentation › Oral presentation › Teaching and Research
-
BSH 2023 Zanubrutinib in Patients With Relapsed/Refractory Marginal Zone Lymphoma (MZL): Final Analysis of MAGNOLIA (BGB-3111-214)
Linton, K. (Speaker)
Apr 2023Activity: Talk or presentation › Oral presentation › Research
-
BRAINatomy: an update
Mccabe, M. (Speaker)
31 Jan 2023Activity: Talk or presentation › Oral presentation › Research
-
Pairwise Comparisons of The Four Chemotherapy Regimens Initially Included in The Reecur Trial for The Treatment of Primary Refractory and Recurrent Ewing Sarcoma (RR-ES)
Mccabe, M. (Speaker)
18 Nov 2022Activity: Talk or presentation › Oral presentation › Research
-
UK MZL and MCL forum talks
Linton, K. (Speaker)
5 Sept 2022 → 6 Sept 2022Activity: Talk or presentation › Oral presentation › Teaching and Research
-
Phase III assessment of topotecan & cyclophosphamide and high-dose ifosfamide in rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)
Mccabe, M. (Speaker)
5 Jun 2022Activity: Talk or presentation › Oral presentation › Research
-
Results of the second interim assessment of rEECur, an international randomized controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma (RR-ES)
Mccabe, M. (Speaker)
29 May 2020Activity: Talk or presentation › Oral presentation › Research
-
Radiotherapy / Modelling and theranostics
Van Herk, M. (Speaker)
29 Aug 2019Activity: Talk or presentation › Oral presentation › Research
-
Highlight talk: Restoring a Data General Nova computer used in the first CT scanner
Van Herk, M. (Speaker)
18 Jun 2019Activity: Talk or presentation › Oral presentation › Research
-
Comparing two web platforms for uncertainty simulation of external beam radiotherapy
Van Herk, M. (Speaker)
17 Jun 2019Activity: Talk or presentation › Oral presentation › Research
-
Dose Calculation and Optimisation
Van Herk, M. (Speaker)
13 Jun 2019Activity: Talk or presentation › Oral presentation › Research
-
Results of the first interim assessment of rEECur, an international randomised controlled trial of chemotherapy for the treatment of recurrent and primary refractory Ewing sarcoma
Mccabe, M. (Speaker)
2 Jun 2019Activity: Talk or presentation › Oral presentation › Research
-
Characterising dose changes due to unplanned gas cavities in Magnetic Resonance guided Radiotherapy
Shortall, J. (Speaker)
2019Activity: Talk or presentation › Oral presentation › Research
-
Inter-fractional stability of rectal gas in cervical cancer patients
Shortall, J. (Speaker)
2019Activity: Talk or presentation › Oral presentation › Research
-
Visiting Professorship: Maryland Proton Treatment Center, Baltimore
Faivre-Finn, C. (Discussant)
Dec 2018Activity: Talk or presentation › Oral presentation › Research
-
Immunotherapy: Evolving paradigms in GU cancers
Choudhury, A. (Discussant)
8 Nov 2018Activity: Talk or presentation › Oral presentation › Research
-
Visiting Professorship: Memorial Sloan Kettering Cancer Center, May2018
Faivre-Finn, C. (Discussant)
May 2018Activity: Talk or presentation › Oral presentation › Research
-
Visiting Professorship: Institut de Cancerlogie Gustave Roussy, Paris
Faivre-Finn, C. (Discussant)
2018Activity: Talk or presentation › Oral presentation › Research
-
Perioperative chemotherapy for upper tract urothelial cancers
Choudhury, A. (Discussant)
18 Nov 2017Activity: Talk or presentation › Oral presentation › Research
-
Best of Radiotherapy
Choudhury, A. (Speaker)
17 Nov 2017Activity: Talk or presentation › Oral presentation › Research
-
Microenvironmental and epigenetic mechanisms underlying the development and maintenance of haematopoietic stem and progenitor cells.
Batta, K. (Discussant)
14 Sept 2017Activity: Talk or presentation › Oral presentation › Research
-
Post-treatment lymphocytopaenia, integral heart dose and overall survival in lung cancer patients treated with radical radiotherapy
Choudhury, A. (Speaker)
Sept 2017 → …Activity: Talk or presentation › Oral presentation › Research
-
Molecular subtyping of muscle invasive bladder cancer predicted benefit of hypoxia-targeting therapy
Choudhury, A. (Speaker)
Sept 2017 → …Activity: Talk or presentation › Oral presentation › Research
-
Effects of Registration Uncertainties in Image-based Data Mining
Vasquez Osorio, E. (Discussant)
12 Jun 2017Activity: Talk or presentation › Oral presentation › Research
-
APCCC: What is new in management of prostate cancer
Gillessen Sommer, S. (Discussant)
Jun 2017 → …Activity: Talk or presentation › Oral presentation › Research
-
Poster discussion: Challenges in the management of testicular cancer
Gillessen Sommer, S. (Discussant)
Jun 2017Activity: Talk or presentation › Oral presentation › Research
-
Quantifying Registration Uncertainties in Image-based Data Mining
Vasquez Osorio, E. (Discussant)
7 May 2017Activity: Talk or presentation › Oral presentation › Research
-
Outcomes in Elderly bladder cancer outcomes with bladder preservation
Choudhury, A. (Discussant)
5 May 2017 → 9 May 2017Activity: Talk or presentation › Oral presentation › Research
-
The Management of Women with pre-treatment CIN2
Sivalingam, V. (Discussant)
1 May 2017Activity: Talk or presentation › Oral presentation › Research
-
Assessing the dose significance of unplanned small air cavities in MR Guided Radiotherapy
Shortall, J. (Speaker)
2017Activity: Talk or presentation › Oral presentation › Research
-
Unleashing the immune system on lymphoma
Linton, K. (Invited speaker)
16 Nov 2016Activity: Talk or presentation › Oral presentation › Research
-
Mantle Cell Lymphoma Challenges of Treatment
Linton, K. (Keynote speaker)
6 Oct 2016Activity: Talk or presentation › Oral presentation › Research
-
Diagnosis of Lymphoma. Living with Lymphoma
Linton, K. (Invited speaker)
15 Sept 2016Activity: Talk or presentation › Oral presentation › Research
-
Improving CAR T cell therapy to treat CD19+ malignancies
Kueberuwa, G. (Discussant)
16 May 2016Activity: Talk or presentation › Oral presentation › Research
-
Molecular Subtying of Diffuse Large B-cell Lymphoma - towards a quantigene plex tool
Linton, K. (Discussant)
22 Apr 2015Activity: Talk or presentation › Oral presentation › Research
-
Lecturer ESMO Preceptorship: Immunotherapy for Lymphoma
Linton, K. (Invited speaker)
24 Jan 2015Activity: Talk or presentation › Oral presentation › Research
File